Targeted therapy: Leveraging ADCC to enhance anti-HER2 therapy.
Nat Rev Clin Oncol. 2017 Feb 14;:
Authors: Killock D
PMID: 28195234 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου